RARP Prostate Cancer Surgery Causes Fewer Urinary, Sexual Problems Than Brachytherapy, Italian Study Finds

RARP Prostate Cancer Surgery Causes Fewer Urinary, Sexual Problems Than Brachytherapy, Italian Study Finds
Men with low-risk prostate cancer have similar recurrence-free survival rates when treated with surgical robotic prostatectomy or brachytherapy, but those who received surgery had fewer urinary or sexual problems two years after treatment, a randomized trial in Italy has concluded. The study, “Robotic prostatectomy versus brachytherapy for the treatment of low-risk prostate cancer,” appeared in the Canadian

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

5 comments

  1. Lawrence Glickman says:

    Why did you not even mention the large and growing treatment options for prostate cancer? If the patient has organ confined early stage PC all practitioners should always inform the patient that there is HIFU,CRYO, Tookad, CYBER KNIFE, and more in Europe. BT and RS have been the standard but have no advantage in early stage results. The newer therapies have fewer side effects and shorter treatment times and are often less expensive. Patients are usually uniformed and take the offer made by their primary Doctor. This needs to change.

  2. Darryl Baillie says:

    I can’t believe this article…. Anyone that says “Regarding sexual function, both groups showed a decreased ability to maintain an erection right after treatment. However, RARP-treated men recovered potency much more quickly than their BP-treated counterparts. By the final follow-up, 90 percent of RARP-treated men were back to normal, compared to only 60 percent of men in the BT group.” is living in fairy land…There is no way that 90% of RARP patients are normal at 2,3 or 5yrs post op! This article smells like a Da Vinci advertisment.

    • Tim Bossie says:

      Hi Darryl, we can certainly understand your skepticism regarding this, but we are only reporting on what the study finds.

  3. Darryl Baillie says:

    Hi Tim
    The article states quite clearly that 90% who underwent RARP had “normal” sexual function at the end of two yrs… Samadi’s article in PRweb clearly uses the definition as “the ability to achieve and maintain satisfactory erections for sexual intercourse or potency, with or without the use of PDE-5 inhibitors.” From experience and active membership of many forums I can tell you the final result is marginal and far from normal or satisfactory. Be careful when summarising somebody elses article not to embellish perceived benefits. Using the word “normal” is clearly embellishing the final result. Here is an article from a forum you may wish to read…https://www.inspire.com/groups/us-too-prostate-cancer/discussion/after-rp-does-anyone-not-suffer-from-ed/?page=1#replies
    The conversation drifts a little but the theme is there…I understand 77% of men are impotent 2 yrs post surgery whether robotic or open surgery!! Samadi sells robotic surgery and his claims are amasing … I mean really amasing yet Sloan Kettering Memorial Hospital touts figures not too dissimilar to my understanding and they have the best of the best surgeons in the world.
    My surgeon told my wife and I that all his patients had return of function ..but maybe 1 in 200 did not. Later (about 3yrs) his practice released a video explaining the procedure and outcomes and it was explained that hardly any men had return of function at 2 yrs and they could offer a prosthesis…. get my drift??

    • Tim Bossie says:

      Hey Darryl, I get where you’re coming from. I am not doubting your statement in any way. I am simply highlighting the fact that we report on the findings of different studies and are not drawing any conclusions ourselves.

Leave a Comment

Your email address will not be published. Required fields are marked *